Ligand Binding Pocket Formed by Evolutionarily Conserved Residues in the Glucagon-like Peptide-1 (GLP-1) Receptor Core Domain*

Background: Little is known about the interaction between GLP-1 and the heptahelical core domain of GLP1R. Results: GLP-1 Asp9 and Gly4 interact with the evolutionarily conserved residues in extracellular loop 3. Conclusion: Ligand binding pocket formed by evolutionarily conserved residues in the GLP1R core domain. Significance: This study highlights the mechanism underlying high affinity interaction between GLP-1 and the binding pocket of the receptor. Glucagon-like peptide-1 (GLP-1) plays a pivotal role in glucose homeostasis through its receptor GLP1R. Due to its multiple beneficial effects, GLP-1 has gained great attention for treatment of type 2 diabetes and obesity. However, little is known about the molecular mechanism underlying the interaction of GLP-1 with the heptahelical core domain of GLP1R conferring high affinity ligand binding and ligand-induced receptor activation. Here, using chimeric and point-mutated GLP1R, we determined that the evolutionarily conserved amino acid residue Arg380 flanked by hydrophobic Leu379 and Phe381 in extracellular loop 3 (ECL3) may have an interaction with Asp9 and Gly4 of the GLP-1 peptide. The molecular modeling study showed that Ile196 at transmembrane helix 2, Met233 at ECL1, and Asn302 at ECL2 of GLP1R have contacts with His1 and Thr7 of GLP-1. This study may shed light on the mechanism underlying high affinity interaction between the ligand and the binding pocket that is formed by these conserved residues in the GLP1R core domain.

• Publication year

  2015

• Venue

  Journal of Biological Chemistry

• Publication date

  2015-01-05

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1074/jbc.M114.612606PMID 25561730PMCID PMC4342481
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Molecular evolution of GPCRs: GLP1/GLP1 receptors.

  2014cited by this paper
• Expansion of secretin-like G protein-coupled receptors and their peptide ligands via local duplications before and after two rounds of whole-genome duplication.

  2013cited by this paper
• Structure of the human glucagon class B G-protein-coupled receptor

  2013cited by this paper
• Structure of class B GPCR corticotropin-releasing factor receptor 1

  2013cited by this paper
• A Novel Glucagon-Related Peptide (GCRP) and Its Receptor GCRPR Account for Coevolution of Their Family Members in Vertebrates

  2013cited by this paper
• Predicted structure of agonist-bound glucagon-like peptide 1 receptor, a class B G protein-coupled receptor

  2012cited by this paper
• Molecular basis for negative regulation of the glucagon receptor

  2012influential reference
• Diversity and modularity of G protein-coupled receptor structures.

  2012cited by this paper
• Structural and Molecular Conservation of Glucagon-Like Peptide-1 and Its Receptor Confers Selective Ligand-Receptor Interaction

  2012influential reference
• Discovery of a novel glucagon-like peptide (GCGL) and its receptor (GCGLR) in chickens: evidence for the existence of GCGL and GCGLR genes in nonmammalian vertebrates.

  2012influential reference
• Residues within the transmembrane domain of the glucagon-like peptide-1 receptor involved in ligand binding and receptor activation: modelling the ligand-bound receptor.

  2011cited by this paper
• Evolutionarily Conserved Residues at Glucagon-like Peptide-1 (GLP-1) Receptor Core Confer Ligand-induced Receptor Activation*

  2011influential reference
• Conformational and molecular interaction studies of glucagon‐like peptide‐2 with its N‐terminal extracellular receptor domain

  2011cited by this paper
• Second Extracellular Loop of Human Glucagon-like Peptide-1 Receptor (GLP-1R) Has a Critical Role in GLP-1 Peptide Binding and Receptor Activation*

  2011cited by this paper
• Insulin contributes to fine-tuning of the pancreatic beta-cell response to glucagon-like peptide-1

  2011cited by this paper
• LigPlot+: Multiple Ligand-Protein Interaction Diagrams for Drug Discovery

  2011cited by this paper
• Refinement of Glucagon-like Peptide 1 Docking to Its Intact Receptor Using Mid-region Photolabile Probes and Molecular Modeling*

  2011influential reference
• Second Extracellular Loop of Human Glucagon-like Peptide-1 Receptor (GLP-1R) Differentially Regulates Orthosteric but Not Allosteric Agonist Binding and Function*

  2011cited by this paper
• Novel Small Molecule Glucagon-Like Peptide-1 Receptor Agonist Stimulates Insulin Secretion in Rodents and From Human Islets

  2010cited by this paper
• Tyr1 and Ile7 of glucose-dependent insulinotropic polypeptide (GIP) confer differential ligand selectivity toward GIP and glucagon-like peptide-1 receptors

  2010cited by this paper
• Spatial Approximations between Residues 6 and 12 in the Amino-terminal Region of Glucagon-like Peptide 1 and Its Receptor

  2010cited by this paper
• Crystal Structure of Glucagon-like Peptide-1 in Complex with the Extracellular Domain of the Glucagon-like Peptide-1 Receptor*

  2009influential reference
• Molecular modeling of the three-dimensional structure of GLP-1R and its interactions with several agonists

  2009cited by this paper
• Molecular Basis of Glucagon-like Peptide 1 Docking to Its Intact Receptor Studied with Carboxyl-terminal Photolabile Probes*

  2009cited by this paper
• Molecular evolution of multiple forms of kisspeptins and GPR54 receptors in vertebrates.

  2009cited by this paper
• Crystal Structure of the Ligand-bound Glucagon-like Peptide-1 Receptor Extracellular Domain*

  2008influential reference
• Small-molecule agonists for the glucagon-like peptide 1 receptor

  2007cited by this paper
• The bioactive conformation of glucose‐dependent insulinotropic polypeptide by NMR and CD spectroscopy

  2007cited by this paper
• Molecular evolution of neuropeptide receptors with regard to maintaining high affinity to their authentic ligands.

  2007cited by this paper
• Crystal structure of the incretin-bound extracellular domain of a G protein-coupled receptor

  2007influential reference
• Cellular and molecular biology of orphan G protein-coupled receptors.

  2006cited by this paper
• Peptide Agonist Docking in the N-terminal Ectodomain of a Class II G Protein-coupled Receptor, the VPAC1 Receptor

  2006cited by this paper
• Turn-on switch in parathyroid hormone receptor by a two-step parathyroid hormone binding mechanism.

  2005cited by this paper
• Extracellular Loop 3 (EL3) and EL3-Proximal Transmembrane Helix 7 of the Mammalian Type I and Type II Gonadotropin-Releasing Hormone (GnRH) Receptors Determine Differential Ligand Selectivity to GnRH-I and GnRH-II

  2005cited by this paper
• Identification of Amino Acid Residues That Direct Differential Ligand Selectivity of Mammalian and Nonmammalian V1a Type Receptors for Arginine Vasopressin and Vasotocin

  2004cited by this paper
• Glucagon-like peptide 1 agonists and the development and growth of pancreatic β-cells

  2004cited by this paper
• Met-204 and Tyr-205 are together important for binding GLP-1 receptor agonists but not their N-terminally truncated analogues.

  2004cited by this paper
• Position of Pro and Ser near Glu7.32 in the extracellular loop 3 of mammalian and nonmammalian gonadotropin-releasing hormone (GnRH) receptors is a critical determinant for differential ligand selectivity for mammalian GnRH and chicken GnRH-II.

  2004cited by this paper
• Glucagon-like peptide 1 agonists and the development and growth of pancreatic beta-cells.

  2004cited by this paper
• Three Distinct Epitopes on the Extracellular Face of the Glucagon Receptor Determine Specificity for the Glucagon Amino Terminus*

  2003cited by this paper
• Glucagon-like peptides: regulators of cell proliferation, differentiation, and apoptosis.

  2003cited by this paper
• A model for receptor–peptide binding at the glucagon‐like peptide‐1 (GLP‐1) receptor through the analysis of truncated ligands and receptors

  2003cited by this paper
• Different domains of the glucagon and glucagon‐like peptide‐1 receptors provide the critical determinants of ligand selectivity

  2003cited by this paper
• Spatial Approximation between Two Residues in the Mid-region of Secretin and the Amino Terminus of Its Receptor

  2003cited by this paper
• The Isolated N-terminal Domain of the Glucagon-like Peptide-1 (GLP-1) Receptor Binds Exendin Peptides with Much Higher Affinity than GLP-1*

  2003cited by this paper
• The glucagon‐like peptide‐1 receptor binding site for the N‐terminus of GLP‐1 requires polarity at Asp198 rather than negative charge

  2002cited by this paper
• Mutational analysis of the glucagon receptor: similarities with the vasoactive intestinal peptide (VIP)/pituitary adenylate cyclase-activating peptide (PACAP)/secretin receptors for recognition of the ligand's third residue.

  2002cited by this paper
• Effects of glucagon-like peptide 1 on counterregulatory hormone responses, cognitive functions, and insulin secretion during hyperinsulinemic, stepped hypoglycemic clamp experiments in healthy volunteers.

  2002cited by this paper
• Effect of 6-week course of glucagon-like peptide 1 on glycaemic control, insulin sensitivity, and beta-cell function in type 2 diabetes: a parallel-group study.

  2002cited by this paper
• Exendin-4 and glucagon-like-peptide-1: NMR structural comparisons in the solution and micelle-associated states.

  2001cited by this paper
• Rapid boundary element solvation electrostatics calculations in folding simulations: successful folding of a 23-residue peptide.

  2001cited by this paper
• Family-B G-protein-coupled receptors

  2001cited by this paper
• Predicting transmembrane protein topology with a hidden Markov model: application to complete genomes.

  2001cited by this paper
• Characterization of glucagon-like peptide-1 receptor-binding determinants.

  2000cited by this paper
• Structural determinants for activity of glucagon-like peptide-2.

  2000cited by this paper
• High Potency Antagonists of the Pancreatic Glucagon-like Peptide-1 Receptor*

  1997cited by this paper
• Cell and molecular biology of the incretin hormones glucagon-like peptide-I and glucose-dependent insulin releasing polypeptide.

  1995cited by this paper
• Degradation of glucose-dependent insulinotropic polypeptide and truncated glucagon-like peptide 1 in vitro and in vivo by dipeptidyl peptidase IV.

  1995cited by this paper
• Structure-activity studies of glucagon-like peptide-1.

  1994cited by this paper
• Structure/activity characterization of glucagon-like peptide-1.

  1994cited by this paper
• Cloning and Functional Expression of the Human Islet GLP-1 Receptor: Demonstration That Exendin-4 Is an Agonist and Exendin-(9–39) an Antagonist of the Receptor

  1993cited by this paper
• Dipeptidyl-peptidase IV hydrolyses gastric inhibitory polypeptide, glucagon-like peptide-1(7-36)amide, peptide histidine methionine and is responsible for their degradation in human serum.

  1993cited by this paper
• Comparative protein modelling by satisfaction of spatial restraints.

  1993cited by this paper
• Preproglucagon gene expression in pancreas and intestine diversifies at the level of post-translational processing.

  1986cited by this paper

• Understanding VPAC receptor family peptide binding and selectivity

  2022cites this paper
• Effects of site-directed mutagenesis of GLP-1 and glucagon receptors on signal transduction activated by dual and triple agonists

  2022cites this paper
• Mutational Landscape of the Proglucagon-Derived Peptides

  2021cites this paper
• Naturally occurring mutations in G protein-coupled receptors associated with obesity and type 2 diabetes mellitus.

  2021cites this paper
• Exploring the molecular structures that confer ligand selectivity for galanin type II and III receptors

  2020cites this paper
• The Effects of a Weight-Loss Herbal Formula RCM-107 and Its Eight Individual Ingredients on Glucagon-Like Peptide-1 Secretion—An In Vitro and In Silico Study

  2020cites this paper
• Glucagon-like peptide 1 (GLP-1)

  2019cites this paper
• This is a repository copy of A mechanism for agonist activation of the glucagon-like peptide-1 (GLP-1) receptor through modelling

  2019cites this paper
• A mechanism for agonist activation of the glucagon-like peptide-1 (GLP-1) receptor through modelling & molecular dynamics.

  2018cites this paper
• Phase-plate cryo-EM structure of a biased agonist-bound human GLP-1 receptor–Gs complex

  2018cites this paper
• Structure of the glucagon receptor in complex with a glucagon analogue

  2018cites this paper
• Helixconstraints and amino acid substitution in GLP-1 increase cAMP and insulin secretion but not beta-arrestin 2 signaling.

  2017cites this paper
• Extending the Structural View of Class B GPCRs.

  2017cites this paper
• Evolutionary and Comparative Genomics to Drive Rational Drug Design, with Particular Focus on Neuropeptide Seven-Transmembrane Receptors

  2017cites this paper
• Crystal structure of the GLP-1 receptor bound to a peptide agonist

  2017cites this paper
• Structural Determinants of Binding the Seven-transmembrane Domain of the Glucagon-like Peptide-1 Receptor

  2016influential citation
• An intrinsic agonist mechanism for activation of glucagon-like peptide-1 receptor by its extracellular domain

  2016cites this paper
• Structural Mapping and Functional Characterization of Zebrafish Class B G-Protein Coupled Receptor (GPCR) with Dual Ligand Selectivity towards GLP-1 and Glucagon

  2016cites this paper
• The Extracellular Surface of the GLP-1 Receptor Is a Molecular Trigger for Biased Agonism

  2016influential citation
• Development of Spexin-based Human Galanin Receptor Type II-Specific Agonists with Increased Stability in Serum and Anxiolytic Effect in Mice

  2016cites this paper
• A Hydrogen-Bonded Polar Network in the Core of the Glucagon-Like Peptide-1 Receptor Is a Fulcrum for Biased Agonism: Lessons from Class B Crystal Structures

  2016cites this paper
• Positive Allosteric Modulation of the Glucagon-like Peptide-1 Receptor by Diverse Electrophiles*

  2016cites this paper
• Structural Determinants of Binding the Seven-transmembrane Domain of the Glucagon-like Peptide-1 Receptor (GLP-1R)*

  2016cites this paper
• Computational insight into conformational states of glucagon-like peptide-1 receptor (GLP-1R) and its binding mode with GLP-1

  2016cites this paper
• Glucagon-Like Peptide-1 and Its Class B G Protein–Coupled Receptors: A Long March to Therapeutic Successes

  2016cites this paper
• The peptide agonist-binding site of the glucagon-like peptide-1 (GLP-1) receptor based on site-directed mutagenesis and knowledge-based modelling

  2015cites this paper
• Expanding the horizons of G protein-coupled receptor structure-based ligand discovery and optimization using homology models.

  2015cites this paper